InterShunt: Funding, Investors & Team (Sep 2026)
InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe they can do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.
InterShunt has raised $4.0M across 3 funding rounds on record, the most recent an undisclosed round announced in Jun 2023.
InterShunt Company Profile and Key Stats
Latest funding round on record: Jun 2023.
InterShunt Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
InterShunt raised $3.1M in an undisclosed round announced in Jan 2021.
11 months later, an Undisclosed of $900k was announced in Dec 2021.
1.5 years later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
InterShunt Founders and Leadership Team
Contact details for the InterShunt team: 2 of 2 have an email address on file.
Start 14-day free trial →InterShunt Funding Compared to Other Biotechnology Startups
Funded Startups Like InterShunt in Biotechnology and St Louis
Companies Similar to InterShunt
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
InterShunt Funding FAQs
What does InterShunt do?
InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe they can do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.
How much funding has InterShunt raised?
InterShunt has raised $4.0M across 3 rounds on record.
When did InterShunt last raise funding?
InterShunt's most recent funding round on record was announced in Jun 2023. The amount was not disclosed.
Who founded InterShunt?
FundedIQ lists Gil Vardi (Founder) at InterShunt.
Who is the CEO of InterShunt?
Harlee Sorkin is listed as CEO at InterShunt.
Where is InterShunt headquartered?
InterShunt is based in St Louis, Missouri, United States.
How many employees does InterShunt have?
InterShunt is in the 1-10 employee band.
About FundedIQ's InterShunt Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InterShunt is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.